Regenxbio RGNX
NASDAQ RGNX
$8.95 -0.25 (-2.72%)
As of: Sep 4, 2026 · 3:57 PM EDT

Regenxbio (RGNX) EPS (Basic) (2014 - 2026)

Regenxbio (RGNX) posted quarterly EPS (Basic) of $1.74 for Q4 2025, up 229.43% year-over-year from $0.53 in Q4 2024, and up 237.48% quarter-over-quarter from -$1.27 in Q3 2025.

Analysis

Regenxbio (RGNX) EPS (Basic) (2014 - 2026) Analysis & Trends

Regenxbio's EPS (Basic) history runs 12 years deep, the most recent figure standing at $1.74 for Q4 2025.

  • In Q4 2025, EPS (Basic) rose 229.43% year-over-year to $1.74; the TTM figure through Dec 2025 stood at -$0.83 (up 83.79% YoY), while the FY2025 annual figure was -$10.38, down 122.95% from the prior year.
  • EPS (Basic) for Q4 2025 stood at $1.74, up from -$1.27 in the prior quarter.
  • The five-year high for EPS (Basic) was $6.93 in Q4 2021, with the low at -$1786.6 in Q1 2022.
  • The 5-year median for EPS (Basic) is -$1.36 (2021), against an average of -$485.45.
  • The sharpest annual moves came in 2021 and 2022: EPS (Basic) jumped 658.58% in 2021, then plunged 148911.94% in 2022.
  • Regenxbio's EPS (Basic) stood at $6.93 in 2021, then fell by 6.61% to $6.47 in 2022, then tumbled by 122.25% to -$1.44 in 2023, then grew by 6.54% to -$1.35 in 2024, then soared by 229.43% to $1.74 in 2025.
  • Business Quant data shows RGNX's EPS (Basic) at $1.74 in Q4 2025, -$1.27 in Q3 2025, and -$1.38 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 12.62
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7.70
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.33 Bn 44.33 Bn - -3.06
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.23
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.18
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.06
10 Regenxbio 472.74 Mn 367.22 Mn - 0.43
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.43
Dec 31, 2025 -1.30
Sep 30, 2025 -1.20
Jun 30, 2025 -1.38
Mar 31, 2025 0.12
Dec 31, 2024 -1.04
Sep 30, 2024 -1.17
Jun 30, 2024 -1.05
Mar 31, 2024 -1.39
Dec 31, 2023 -1.44
Sep 30, 2023 -1.41
Jun 30, 2023 -1.66
Mar 31, 2023 -1.53
Dec 31, 2022 -0.03
Sep 30, 2022 -1.75
Jun 30, 2022 -1.58
Mar 31, 2022 -1.79
Dec 31, 2021 6.93
Sep 30, 2021 -1.37
Jun 30, 2021 -1.36